Tyk2-IN-19
Tyk2-IN-19 (Compound 1) is an orally active and blood-brain barrier (BBB) permeable Tyk2 inhibitor. Tyk2-IN-19 can be used for study of neurodegenerative diseases[1].
Product Specifications
CAS Number
[2866415-98-5]
UNSPSC
12352005
Target
JAK
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/tyk2-in-19.html
Purity
98.62
Solubility
DMSO : 16.67 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(CC)C1=C(NC2=C(OC)C(C3=NN(C)N=C3)=CC=N2)C=C(NC(C4CC4)=O)N=C1
Molecular Formula
C21H23N7O3
Molecular Weight
421.45
References & Citations
[1]Steven H. Spergel, et al. Substituted heterocyclic compounds. US20240124421A1. 2024-04-18.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MA2 (Paraneoplastic Antigen Ma2, 40kD Neuronal Protein, PNMA2, Onconeuronal Antigen Ma2, Paraneoplastic Neuronal Antigen MM2, KIAA0883) (MaxLight 490)
MA2 (Paraneoplastic Antigen Ma2, 40kD Neuronal Protein, PNMA2, Onconeuronal Antigen Ma2, Paraneoplastic Neuronal Antigen MM2, KIAA0883) (MaxLight 490)